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Abstract: Chiral complexes formed by privileged phosphoramidites, from chiral binol and optically pure Davies’ 
amines, and copper(II) triflate, silver(I) triflate or silver(I) benzoate are excellent catalysts for the general 1,3-dipolar 
cycloaddition between azomethine ylides generated from α-amino acids derived imino esters and nitroalkenes. These 
three methods afford at room temperature high diastereoselectivityofexo-cycloadducts (4,5-trans-2,5-cis-4-
nitroprolinates) in high enantioselectivity. In general, the three procedures are complementary but silver catalysts are 
more versatile and less sensitive to sterically congested starting materials.  
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Scheme 1. General procedures for the synthesis of polysubstituted exo-nitroprolinates 4. 
 
Introduction 
The straightforward synthesis of enantiomerically 
enriched polysubstituted exo-4-nitroprolinates can be 
achieved through a 1,3-dipolar cycloaddition (1,3-
DC)1 between imino esters and nitroalkenes.2 The 
introduction of the versatile nitro group at the 4-
position of the pyrrolidine skeleton enhances the 
interest of these chiral molecules. Particularly,exo-4-
nitroprolinates with a specific 2,5-cis-4,5-trans-
configuration have been used as leukocyte function 
associated antigen-1 antagonists during a cancer 
evolution,3 with important activity as inhibitors of 
α4β1-integrin-mediated hepatic melanoma metastasis  
and even for treatments of other diseases.4 More 
simple exo-nitroprolinates such as 4 have shown a 
high efficiency as organocatalysts in asymmetric aldol 
reactions.5 
For the construction of these exo-prolinates with 2,5-
cis-4,5-trans arrangement, N-arylideneamino esters 
have been employed as azomethine ylide precursors in 
the enantioselective 1,3-DC with nitroalkenes 
employing both organocatalysts and metal complexes 
as chiral catalysts.6 The major contributions using α-
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imino esters to get exo-adducts were achieved under 
the control of chiral metal complexes.7 Chiral Lewis 
acids formed by copper(I), copper(II), gold(I), and 
nickel(II) complexes were the most effective.2The 
only exception reported in all these examples is the 
employment of a copper(II) triflate·pyridyl 
bis(imidazolidine) as chiral complex,8 andvery 
interesting switchable chiral P,N-ferrocene 
ligands,9which afforded the endo-adducts. 
Taking in account that silver(I) is traditionally the 
most suitable cation to stabilize a metallodipole 
derived from iminoesters 3,10 any efficient 1,3-DC 
with β−nitroalkenes has been reported.11 Only 
Fukuzawa’s group published a highly effective 
asymmetric cycloaddition using benzophenone-
derived iminoglycinates and nitroalkenes catalyzed by 
silver(I)·thioclickferrophos complexes.12 
Very recently, we have shown that 
phosphoramidites,13,14 derived from chiral binol-chiral 
Davies’ amines, represented a matched combination 
for the enantioselective 1,3-dipolar cycloaddition (1,3-
DC)15 between nitroalkenes and azomethine ylides 
derived from imino esters. Cu(OTf)2 16and silver(I) 
salts17 afforded exo-4-nitroprolinates in high 
diastereomeric ratios and enantioselectivities. Seminal 
works published in the literature concerning 
asymmetric 1,3-CD of imino esters and different 
dipolarophiles catalyzed by chiral phosphoramidite 
1·silver(I)complexes supported this idea,18obtaining, 
enantiomerically enriched polysubstituted endo-
proline derivatives in good chemical yields and 
excellent both diastereo- and enantioselections.  
Herein, we wish to report a practical procedure for the 
synthesis ofexo-4-nitroprolinates 4 in which 
nitroalkenes underwent copper(II) and the less known 
silver(I)-catalyzed 1,3-dipolar cycloaddition with 
azomethine ylides obtained from α-imino esters. 
Scope and Limitations 
The scope of the reaction was studied with different 
nitroalkenes 3, employing various arylideneimino 
esters 2 under the control of: a) the catalyst formed by 
phosphoramidite(Sa,R,R)-1 and Cu(OTf)2 (Scheme 
1, Procedure 1, Table 1); b)the catalyst originated 
by (Sa,R,R)-1 and AgOTf (Scheme 1, Procedure 2, 
Table 1), and; c) the combination of 
phosphoramidite (Sa,R,R)-1 with AgOBz (Scheme 
1, Procedure 2, Table 1). Initially, the influence of the 
ester moiety of imines 2 was surveyed. Compound 4a 
was obtained as very clear crude reaction product and 
with the highest er in the presence of (Sa,R,R)-
1·AgOBz complex (Table 1, entry 1).When the 
isopropyl ester of the corresponding dipole precursor 
was used, instead of the methyl ester, almost identical 
er for the reactions catalyzed by the two chiral silver 
complexes with a slightly better exo-diastereoselection 
for the isopropyl ester was obtained. The copper(II) 
catalyzed process gave better exo/endo and similar 
enantiomeric ratios. However, the lower yields(up to 
70%) of the exo-product 4b mixtures obtained in all of 
the reactions using the isopropyl ester obeyed to the 
appearance of a proportion of other unidentified 
diastereoisomers (ca. 20-28% from crude product 
determined by 1H NMR), (Table 1, entry 2). In 
consequence, the study of the scope of the reaction 
was next done with methyl α-imino esters as metallo-
azomethine ylide precursors. 
 
The study of the influence of the aryl substituent of 
the nitroalkene 3 for the 1,3-DC with methyl 
benzylidene glycinate revealed that, in general, higher 
chemical yields, exo-diastereoselectivities and 
enantioselections in products 4c-g were observed 
when the reactions occurred in the presence of 
(Sa,R,R)-1·AgOBz rather than with the silver(I) or 
copper(II) triflates(Table 1, entries 3-7). Only one 
exception was recorded when m-brominated 
nitrostyrene was employed as dipolarophile (Table 1, 
entry 6). In this example, (Sa,R,R)-1·Cu(OTf)2 
complex was the most effective catalyst giving the 
cleanest crude compound 4f (90/10 dr, and 96:4 er). 
In the case of the heteroaromatic moiety bonded to the 
nitro component (2-furyl) was more appropriate with 
the chiral silver benzoate complex achieving 77% of 
chemical yield and 98% ee of the exo-4h (Table 2, 
entry 8). When the nitroalkene 3 beared an aliphatic 
cyclohexyl group a reversal diastereoselectivity was 
observed in the 1·AgOTf catalyzed 1,3-DC. The 
exclusive endo isomer was isolated in 71% yield but 
as a racemic mixture. However, an equimolar mixture 
of endo/exo diastereoisomers, in 75% overall yield, 
was isolated in the analogous reaction performed with 
AgOBz. Again, the adduct endo-4i was separated as a 
racemate, whilst the exo-isomer 4i was obtained in 
low 32% yield but with a 96% ee (Table 2, entry 9). 
On the other hand, the 1,3-DC with this nitroalkene3 
(R2 = Cy) failed with the Cu(OTf)2 complex. 
 
When alanine, leucine, and phenylalanine derived 
imino esters 2 were used as azomethine ylide 
precursors, an increment of the endo-diastereoisomers 
4j-l was observed. This diastereoisomer was always 
obtained as a racemic mixture (Table 1, entries 10-
12). Alanine dipole precursor2 furnished very low 
proportions of exo-4j, which was isolated with high 
optical purity in silver-catalyzed processes (Table 1, 
entry 10). The other two quaternized pyrrolidines exo-
4k, and exo-4l were satisfactorily isolated (>99:1 er) 
by employing (Sa,R,R)-1·Cu(OTf)2 catalysis (Table 1, 
entries 11 and 12). 
 
With respect to the reaction of different methyl 
arylideneimino glycinates 2with nitrostyrene, the 
more sterically hindered o-tolyl imino group also 
favoured the generation of the endo-isomer 4m but in 
less proportion in the case of AgOBz (Table 1, entry 
13). For the m-tolyl imino group derivative the 
benzoate counteranion gave the highest 
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enantioselections of compound exo-4n (Table 1, entry 
14). It seems that the lower steric repulsion the higher 
proportion of exo-adduct and enantioselection. This 
general assumption can be supported by the 
transformations involving p-substituted arylidene 
imino esters2 (Table 2, entries 15-18). Thus, better 
results for compounds 4o-rwere observed when 
(Sa,R,R)-1·AgOTf was the selected catalyst, rather 
than the processes mediated by the silver benzoate 
(Table 2, entries 15-18). Noticeably, compound exo-
4p could not be prepared through the copper(II)-
catalyzed method (Table 2, entry 16). Finally, in the 
reaction using substrate 2 with a 2-naphthyl 
substituent, productexo-4s was obtained with up to 
72% de and 85% ee when AgOTf was used better than 
Cu(OTf)2 and AgOBz (Table 2, entry 19). 
 
Table 1.Scope of the diastereo- and enantioselective 1,3-DC between imino esters 2 and nitroalkenes 3 catalyzed by, 
(Sa,R,R)-1·Cu(OTf)2, (Sa,R,R)-1·AgOTf, and(Sa,R,R)-1·AgOBz. 
   (Sa,R,R)-1·Cu(OTf)2  (Sa,R,R)-1·AgOTf  (Sa,R,R)-1·AgOBz 
Entry 4 Structure exo/ 
endoa,b 
Yield  
(%)c 
erd  exo/ 
endoa,b 
Yield  
(%)c 
erd  exo/ 
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Yield  
(%)c 
erd 
1 
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N
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>99:1 
 
2 
 
4b 
N
H
Ph
Ph
CO2Pri
O2N
H
 
 
99/1 
 
69  
 
>99:1 
  
98/2 
 
69 
 
98:2 
  
93/7b 
 
70 
 
98:2 
 
 
3 
 
 
4c 
N
H
Ph
CO2Me
O2N
H
 
 
 
82/18 
 
 
48 
 
 
99:1 
  
 
70/30 
 
 
52 
 
 
95:5 
  
 
93/7 
 
 
92 
 
 
99:1 
 
 
4 
 
 
4d 
N
H
Ph
CO2Me
O2N
H
F
 
 
 
82/12 
 
 
73 
 
 
96:4 
  
 
89/11 
 
 
74 
 
 
98:2 
  
 
92/8 
 
 
88 
 
 
>99:1 
 
5 
 
4e 
N
H
Ph
CO2Me
O2N
H
Br
 
 
73/27 
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96:4 
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64 
 
97:3 
  
91:9b 
 
76 
 
96:4 
 
 
6 
 
 
4f 
N
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O2N
H
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61 
 
 
94:6 
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61 
 
 
93:7 
  
 
82/18b 
 
 
61 
 
 
94:6 
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N
H
Ph
CO2Me
O2N
H
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84/16 
 
 
70 
 
 
95:5 
  
 
85/15 
 
 
56 
 
 
99:1 
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99:1 
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__ 
 
 
__ 
 
 
__ 
  
 
1/99 
 
 
71e 
 
 
rac. 
  
 
50/50 
 
 
33d 42e 
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4j 
N
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Ph
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26/74 
 
18 
 
racf 
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14d63e 
 
93:7f 
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96:4f 
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H
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Ph
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60 
 
>99:1f 
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46 
 
98:2 
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12 
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N
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56 
 
95:5 
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N
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N
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77 
 
>99:1 
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N
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86/14 
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85:15 
  
86/14 
 
70 
 
92:8 
  
80/20b 
 
66 
 
88:12 
a From the crude product, determined by 1H NMR. 
bOther stereoisomers were detected in noticeable proportions.  
cIsolated yield (for the exo-adduct) after purification by flash chromatography.  
dFor the exo-stereoisomer (HPLC). 
e For de endo-isomer.  
f The endo-isomer was obtained as a racemic mixture. 
 
 
In these efficient copper(II) or silver(I)-catalyzed 
cycloadditions of nitroalkenes,the influence of the 
position of the anion in the transition state is crucial to 
explain the diastereo- and enantioselectivity of the 
whole process because itself is able to block one of 
the two prochiral faces of the 1,3-dipole. Such as it 
can be deduced from DFT calculations,16,17 triflate 
anion is closer to the copper(II)centre than the 
corresponding silver(I) cation, whereas the distance 
silver(I) cation-dipole is shorter. These reasons justify 
the use of (Sa,R,R)-1·Cu(OTf)2 complex in the 
reactions involving α-substituted imino esters2.  
The influence of the benzoate anion vs. triflate anion 
can be explained by the assumption that benzoate 
(bulkier group than triflate) is oriented along the 
arylidene moiety of the dipole. Thus, a small π-
stacking interaction is observed when 4 (R = H, Ar = 
Ph) is computed so, we think that a variation of this 
aromatic group implies that triflate anion is much less 
sensitive than the benzoate one.19 In this sense, the 
reaction regarding only 4 (R = H, Ar = Ph) and 
nitrostyrenes is optimally catalyzed by (Sa,R,R)-
1·AgOBz complex. In contrast, when different aryl 
substituents are bonded to the 1,3-dipole precursor the 
employment of (Sa,R,R)-1·AgOTf complex is 
desirable.  
In conclusion, an efficient preparation of 
enantiomerically enriched polysubstituted exo-4-
nitroprolinates has been achieved through a 
copper(II)- or silver(I) catalyzed 1,3-DC between 
imino esters and nitroalkenes. This method allows the 
preparation of these pyrrolidines in larger scale (0.5-
0.8 g) at room temperature.(Sa,R,R)-1·AgOBz is the 
best catalyst to perform cycloadditions starting from 
methyl benzylideneglycinate. (Sa,R,R)-1·Cu(OTf)2 
complex is more suitable in the reactions involving α-
substituted imino esters 2. Finally, (Sa,R,R)-1·AgOTf 
catalyst is highly recommended when imines derived 
from aromatic aldehydes (different of benzaldehyde) 
are used. 
Procedures 
Anhydrous solvents were freshly distilled under an argon 
atmosphere and degasified by Freeze-Pump-Thaw 
methodology. Aldehydes were also distilled prior to use for the 
elaboration of the imino esters and nitroalquenes. They are very 
known molecules and are easily prepared. Copper salts were 
dried in a Kugel-Rorh apparatus and stored under an argon 
atmosphere. Melting points were determined with a Reichert 
Thermowar hot plate apparatus and are uncorrected. HPLC 
analyses were performed with a JASCO-2000 series equipped 
with a chiral column by using mixtures of n-hexane/isopropyl 
alcohol as the mobile phase at 25 ºC. Yields refer to isolated 
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compounds estimated to be >95% pure as determined by 1H 
NMR spectroscopy and HPLC analyses. All silver-mediated 
reactions were run avoiding light exposure. 
Copper-Catalyzed Synthesis of exo-Cycloadducts 4. 
Procedure 1 (P1). 
To a solution of the chiral phosphoramidite (0.05 mmol) and 
Cu(OTf)2(0.05 mmol) in dry toluene (3 mL) under argon 
atmosphere was added a solution of imino ester (1mmol) and 
nitroalkene (1 mmol) in toluene (5 mL). To the resulting 
suspension triethylamine (0.05 mmol, 7μL) was added and the 
mixture stirred at room temperature (25 °C) for 16-24 h. The 
crude reaction mixture was filtered through a small celite path. 
The residue was purified by flash chromatography yielding 
pure exo-cycloadducts. Solid products were recrystallized 
inmixtures of n-hexane/ether. 4a and 4f were also prepared in 3 
mmol scale obtaining identical results to the reported for the 
model reaction. 
 
Silver-Catalyzed Synthesis of exo-Cycloadducts 4. 
Procedure 2 (P2-AgOTf) or (P2-AgOBz). 
To a solution of the chiral phosphoramidite 1 (0.05 mmol) and 
AgX (0.05 mmol, triflate or benzoate) in dry toluene (3 mL) 
under argon atmosphere was added a solution of imino ester 
(1mmol) and nitroalkene (1 mmol) in toluene (5 mL). To the 
resulting suspension triethylamine (0.05 mmol, 7µL) was 
added and the mixture stirred at room temperature (25 °C). The 
crude reaction mixture was filtered through a small Celite path. 
The residue was purified by flash chromatography yielding 
pure exo-cycloadducts. Solid products were recrystallized in 
mixtures of n-hexane/ether. Compounds 4a and 4f were also 
prepared in 3 mmol scale obtaining identical results to the 
reported for the model reaction. 
(2S,3S,4R,5S)-Methyl 4-nitro-3,5-diphenylpyrrolidine-2-
carboxylate (4a) 
According to P2-AgOBz, colorless needles, n-hexane/Et2O 4:1. 
mp: 104–105 ºC. 
[α]D20 = 128 (c 1.1, CHCl3), >99:1 er; HPLC: (Daicel 
Chiralpak AS-H), 2-propanol/hexane 20:80, flow rate 0.4 
mL/min, tR: 25.2 min (major) and 27 min (minor), 220 nm;  
IR (solid) νmax: 1265, 1551, 1731 cm-1. 
1H NMR: 2.71 (br s, 1H, NH) 3.26 (s, 3H, Me), 4.35 (t, J = 7.8 
Hz, 1H, CHCO), 4.48 (d, J = 9.1 Hz, 1H, CHPh), 4.73 (d, J = 
7.8 Hz, 1H, CHPh), 5.19 (t, J = 8.0 Hz, 1H, CHNO), 7.45–7.18 
(m, 8H, ArH), 7.56–7.52 (m, 2H, ArH).  
13C-NMR δ: 51.8 (CH3), 53.7 (CHPh), 64.2 (CHCO), 67.5 
(PhCHNH), 95.0 (CHNO2), 126.8, 127.8, 128.1, 128.7, 128.9, 
129.0, 135.8, 137.6 (ArC), 171.8 (CO). 
MS m/z: 326 (M+, 0.1%), 279 (16), 220 (73), 193 (100), 178 
(12), 115 (42). 
EA required for C18H18N2O4: C 66.3, H 5.6, N 8.6%; found: C 
66.4, H 5.3, N 8.6%. 
 
(2S,3R,4R,5S)-Isopropyl 4-nitro-3,5-diphenylpyrrolidine-2-
carboxylate (4b) 
According to P1, colorless needles, n-hexane/Et2O 4:1. 
mp: 130-132 ºC.  
[α]D
20 = 82.3 (c 1.02 CHCl3) >99:1 er; HPLC (Daicel 
Chiralpak AD-H), 2-propanol/hexane 10:90, flow rate 1.0 mL 
min, tR 15.5 min (major), 20.4 min (minor).  
IR (solid) νmax: 1265, 1551, 1731 cm-1.  
1H NMR δ: 0.58 (d, J = 6.3 Hz, 3H, CH3), 1.06 (d, J = 6.3 Hz, 
3H, CH3), 2.75 (br. s, 1H, NH), 4.37 (dd, J = 8.9, 8.0 Hz, 1H, 
CHPh), 4.46 (d, J = 9.1 Hz, 1H, CHCO), 4.65 [dt, J = 12.6, 6.3 
Hz, 1H, CH(CH3)2], 4.75 (d, J = 8.3 Hz, 1H, PhCHN), 5.20 
(dd, J = 8.3, 8.3 Hz, 1H, CHNO2), 7.19-7.30 (m, 5H, ArH), 
7.36-7.45 (m, 3H, ArH), 7.54-7.57 (m, 2H, ArH).  
13C-NMR δ: 20.7 (CH3), 21.6 (CH3), 53.5 (CHPh), 64.1 
(CHCO), 67.4 [CH(CH3)2], 69.1 (PhCHNH), 95.4 (CHNO2), 
126.9, 128.1, 128.8, 128.9, 129.0, 129.4, 136.3, 137.6 (ArC), 
170.8 (CO).  
MS m/z: 356 (M+, 0.01%), 307 (10), 220 (100), 193 (80), 115 
(28).  
HRMS required for (C20H22N2O4-NO2): 309.4021; found 
309.4028.  
EA required for C20H22N2O4: C 67.8, H 6.3, N 7.9%; found: C 
67.4, H 6.3, N 8.3%. 
 
(2S,3S,4R,5S)-Methyl 4-nitro-5-phenyl-3-(p-tolyl)-
pyrrolidine-2-carboxylate (4c). 
According to P2-AgOBz, colorless needles, n-hexane/Et2O 5:1. 
mp 108-110 ºC.  
[α]D20 = 144.8 (c 1.0, CHCl3) 99:1 er. HPLC (Daicel Chiralpak 
AS-H), 2-propanol/n-hexane 5:95, flow rate 1.1 mL/min, tR 
23.2 min (major), 24.2 min (minor).  
IR (neat) νmax: 1212, 1547, 1736, 2917 cm-1.  
1H NMR δ: 2.31 (s, 3H, CH3C), 2.75 (br. s, 1H, NH), 3.32 (s, 
3H, OCH3), 4.35 (dd,  J = 8.5 Hz, 1H, CHTol), 4.48 (d, J = 9 
Hz, 1H, CHCO2Me), 4.76 (d, J = 8.3 Hz, 1H, CHPh), 5.21 (dd, 
J = 8.2, 8.2 Hz, 1H, CHNO2), 7.13 (m, 2H, ArH), 7.40-7.45 
(m, 4H, ArH), 7.55-7.57 (m, 3H, ArH).  
13C-NMR δ: 21.0 (CH3C) 51.9 (CHC6H4Me), 53.5 (CH3), 
64.2 (CHCO2Me), 67.5 (CHPh), 95.1 (CHNO2), 126.9 
(CHCHCHC), 127.7, 129.0, 129.1, 129.4 (ArC), 132.53 
(CH3C), 137.52 (CCHNH), 137.92 (CCHCHNH), 171.86 
(CO).  
MS m/z 294 (M+-NO2, 9%), 234 (36), 207 (100), 129 (15).  
HRMS required for (C19H20N2O4-NO2): 294.1400; found: 
294.1399.  
EA required for C19H20N2O4: C 67.0, H 5.9, N 8.2%; found: C 
67.3, H 6.2, N 7.9%. 
 
(2S,3S,4R,5S)-Methyl 3-(4-fluorophenyl)-4-nitro-5-
phenylpyrrolidine-2-carboxylate (4d). 
According to P2-AgOBz, colorless prisms, n-hexane/Et2O 5:1. 
mp 96.2-97 ºC.  
[α]D20 = 108.1 (c 1, CHCl3) >99:1 er; HPLC (Daicel Chiralpak 
AD-H), 2-propanol/n- hexane 10:90, flow rate 1.0 mL/min, tR 
21.0 min (minor), 28.2 min (major).  
IR (solid) νmax: 1265, 1511, 1553, 1746 cm-1. 
1H NMR δ 2.58 (br. s, 1H, NH), 3.34 (s, 3H, OCH3), 4.34-4.44 
(m, 1H, CHCHCO), 4.51 (d, J = 9.0 Hz, 1H, CHCO2Me), 4.78 
(d, J = 8.2 Hz, 1H, CHPh), 5.16 (dd, J = 8.0, 8.0 Hz, 1H, 
CHNO2), 6.99-7.11 (m, 2H, ArH), 7.23-7.32 (m, 2H, ArH), 
7.36-7.49 (m, 3H, ArH), 7.58 (d, J = 7.5 Hz, 2H, ArH). 
13C NMR δ: 51.9 (CHCHCO), 52.8 (CH3), 64.0 (CHCO), 67.3 
(CHPh), 95.2 (CHNO2), 126.8, 128.9, 129.5, 129.6, 131.8,  
137.6,  161.2,  163.4 (ArC),  171.6 (CO).  
MS m/:z 298 (M+-NO2, 10%), 238 (55), 211 (100), 133 (19), 
117 (18).  
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HRMS required for (C18H17FN2O4-NO2): 298.1181; found: 
298.1175.  
EA required for C18H17N2O4: C 62.8, H 5.0, N 8.1%; found: C 
62.5, H 5.2, N 7.9%. 
 
(2S,3S,4R,5S)-Methyl 3-(2-bromophenyl)-4-nitro-5-
phenylpyrrolidine-2-carboxylate (4e). 
According to P2-AgOBz, pale yellow oil.  
[α]D
20 = 57.7 (c 1.0 CHCl3) 95:5 er, HPLC (Daicel Chiralpak 
AD-H), 2-propanol/n-hexane 10:90, flow rate 1.0 mL/min, tR 
20.1 min (major), 23.9 min (minor). 
IR (neat) νmax: 1549, 1736, 2926 cm-1. 
1H NMR δ 2.53 (br. s, 1H, NH), 3.29 (s, 3H, CH3), 4.70 (d, J = 
9.1 Hz,1H, CHPh), 4.83 (d, J = 8.6 Hz, 1H, CHCO2Me), 4.98 
(dd, J = 9.3, 9.3 Hz, 1H, CHC6H4Br), 5.30 (dd, J = 9.0, 9.0 Hz, 
1H, CHNO2), 7.17 (dd, J = 7.7, 1.4 Hz,1H, ArH), 7.36-7.45 
(m, 6H, ArH), 7.55-7.63 (m, 2H, ArH). 
13C NMR δ: 51.9 (CHAr), 52.2 (CH3), 61.9 (CHCO2Me), 67.2 
(CHPh), 92.9 (CHNO2), 127.1 (CBr), 127.2, 127.8, 128.6, 
128.7, 129.1, 129.2, 133.3, 134.6, 137.3 (ArC), 172.2 (CO). 
 MS m/z 360 (M+-NO2, 28%), 358 (28), 347 (11), 345 (11), 300 
(96), 298 (100), 273 (94), 271 (96), 219 (36), 192 (92).  
HRMS required for (C18H17BrN2O4 –NO2): 359.0338; found: 
359.0343. 
EA required for C18H17BrN2O4: C 53.3, H 4.2, N 6.9%; found 
C 53.1, H 4.1, N 6.5%. 
 
(2S,3S,4R,5S)-Methyl 3-(3-bromophenyl)-4-nitro-5-
phenylpyrrolidine-2-carboxylate (4f). 
According to P1, pale yellow prisms, n-hexane/Et2O 5:1. 
mp 72-74 ºC. 
[α]D20 = 60.5 (c 0.85, CHCl3) 94:6er. HPLC (Daicel Chiralpak 
AD-H), 2-propanol/n-hexane 5:95, flow rate 1.0 mL/min, tR 
41.5 min (minor), 44.3 min (major). 
IR (solid) νmax: 1547, 1735, 2928 cm-1. 
1H NMR δ: 2.73 (br. s, 1H, NH), 3.38 (s, 3H, CH3), 4.33 (dd, 
1H, J = 8.8, 7.8 Hz, CHC6H4Br), 4.50 (d, J = 8.9 Hz, 1H, 
CHCO2Me), 4.75 (d, J = 8.1 Hz, 1H, CHPh), 5.13 (dd, J = 7.9, 
7.9 Hz, 1H, CHNO2), 7.20-7.22 (m, 2H, ArH), 7.41-7.55 (m, 
5H, ArH), 7.55-7.57 (m, 2H, ArH). 
13C NMR δ: 52.0 (CHC6H4Br), 53.0 (CH3), 64.1 (CHCO2Me), 
67.4 (CHPh), 94.9 (CHNO2), 122.8 (CBr), 126.3, 126.9, 129.1, 
129.1, 130.3, 131.2, 131.4, 137.5, 138.4 (ArC), 171.5 (CO). 
MS m/z: 360 (M+-NO2, 17%), 358 (17), 298 (86), 270 (77), 
192 (100), 117 (76). 
HRMS required for (C18H17BrN2O4-NO2): 359.0338; found 
359.0334. 
EA required for C18H17BrN2O4: C 53.3, H 4.2, N 6.9%; found 
C 52.9, H 4.1, N 6.6%. 
 
(2S,3S,4R,5S)-Methyl 3-(4-bromophenyl)-4-nitro-5-
phenylpyrrolidine-2-carboxylate (4g). 
According to P2-AgOBz, colorless prisms, n-hexane/Et2O 4:1. 
mp 89-91ºC.  
[α]D20 = 96.0 (c 0.7, CHCl3), 99:1er. HPLC (Daicel Chiralpak 
AD-H), 2-propanol/n-hexane 10:90, flow rate 1.0 mL/min, tR 
19.4 min (major), 26.8 min (minor). 
IR (solid) νmax: 1544, 1737, 2925 cm-1. 
1H NMR δ: 2.75 (br. s, 1H, NH), 3.34 (s, 3H, CH3), 4.21-4.33 
(m, 1H, CHC6H4Br), 4.48 (d, J = 8.9 Hz, 1H, CHCO2Me), 
4.73 (d, J = 8.1 Hz, 1H, CHPh), 5.08 (dd, J = 7.8, 7.8 Hz, 1H, 
CHNO2), 7.12-7.14 (m, 2H, ArH), 7.37-7.44 (m, 5H, ArH), 
7.50-7.51 (m, 2H, ArH). 
13C NMR δ: 52.0 (CHC6H4Br), 52.9 (CH3), 64.0 (CHCO2Me), 
67.3 (CHPh), 95.1 (CHNO2), 122.3 (CBr), 126.8, 129.0, 129.1, 
129.6, 132.0, 135.3, 137.6 (ArC), 171.5 (CO). 
MS m/z: 360 (M+- NO2, 15%), 359 (15), 300 (52), 298 (51), 
273 (99), 271 (100), 219 (26), 192 (89), 117 (43), 115 (26).  
HRMS required for (C18H17BrN2O4-NO2): 359.0338, found 
359.0330. 
EA required for C18H17BrN2O4: C 53.3, H 4.2, N 6.9%; found: 
C 52.9, H 4.2, N 6.6%. 
 
(2S,3S,4R,5S)-Methyl 3-(furan-2-yl)-4-nitro-5-
phenylpyrrolidine-2-carboxylate (4h). 
According to P2-AgOBz, yellow prisms n-hexane/Et2O 3:1. 
mp 60-62 ºC.  
[α]D20 = 89.0 (c 1,CHCl3) 99:1 er. HPLC (Daicel Chiralpak 
AD-H), 2-propanol/n-hexane 10:90, flow rate 1.0 mL/min, tR 
15.4 min (major), 18.8 min (minor). 
IR (neat) νmax: 1209, 1549, 1740, 2341, 2359 cm-1. 1H NMR δ: 
2.77 (br. s, 1H, NH), 3.51 (s, 3H, OCH3), 4.40 (d, J = 8.5 Hz, 
1H, CHCO), 4.50 (dd, J = 8.4, 7.2 Hz, 1H, CHfuryl), 4.65 (d, J 
= 8.0 Hz, 1H, CHPh), 5.23 (dd, J = 7.9, 7.0 Hz, 1H, CHNO2), 
6.20 (d, J = 3.1 Hz, 1H, CCH), 6.29 (dd, J = 3.2, 1.8 Hz, 1H, 
CCHCHCHO), 7.25–7.61 (m, 6H, ArH and OCH). 
13C NMR δ: 47.9 (CHfuryl), 52.2 (CH3), 63.2(CHCO), 
68.2(CHPh), 93.6 (CHNO2), 108.4 (CCH), 110.5 
(CCHCHCHO), 126.8, 128.6, 128.9, 137.2 (ArC), 142.8 
(OCH), 148.9 (OC), 171.1 (CO). 
MS m/z 270 (M+-NO2, 12%), 183(100), 155(10), 117 (12).  
HRMS required for (C16H16N2O5): 316.1059; found: 
316.1049. 
 
(2S,3R,4S,5S)-Methyl-3-cyclohexyl-4-nitro-5-
phenylpyrrolidine-2-carboxylate  (4i). 
According to P2-AgOBz, white needles. n-hexane/Et2O 4:1. 
mp 125-127 ºC. 
[α]D20 = 0.2 (c 1,0 CHCl3) 52:48 er. HPLC (Chiralpak AD-H, 
2-propanol 10% in  hexane, flow 1.0 mL min, 14.5 min 
(minor), 16.2 min (major).Exo-4i (Chiralpak AD-H, 2-propanol 
10% in  hexane, flow 1.0 mL min, 17.1 min (major), 19.0 min 
(minor). 
IR (neat): 1202, 1544, 1737, 2927 cm-1. 1H-NMR (400 MHz, 
CDCl3) δ: 1.25-1.32 (m, 5H, CH2), 1.58-1.67 [m, 1H, 
CH(CH2)2], 1.72-1.86 (m, 5H, CH2), 2.87 (td, J = 7, 2.4 Hz, 
1H, CHCH(CH2)2), 3.28 (dd, J = 11.5, 10.7 Hz, 1H, NH), 3.83 
(m, 1H, CHCO2Me), 4.47 (dd, J =12.3, 5.9 Hz, 1H, CHPh), 
5.11(dd, J = 5.9, 2.4 Hz, 1H, CHNO2), 7.26-7.35 (m, 5H, ArH). 
13C-NMR (75 MHz, CDCl3) δ: 26.13 (CH2CH2CH2CH), 2 x 
29.94(CH2CH2CH2CH), 2 x 31.51 (CH2CH2CH2CH), 39.73 
(CH2CH2CH2CH), 52.65 (CHCy), 57.09 (CH3), 63.10 
(CHCO2Me), 67.73 (CHPh), 93.33(CHNO2), 126.17, 128.46, 
128.65, 134.26 (ArC), 172.38 (CO). MS m/z (M+-NO2) 285 
(13), 273 (16), 226 (82), 144 (100),117 (28). HRMS required 
for (C18H24N2O4): 332.3934; found: 332.3927. 
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(2S,3S,4S,5S)-Methyl 2-methyl-4-nitro-3,5-
diphenylpirrolidine-2-carboxylate (4j).  
According to P2-AgOTf , yellow oil. 
[α]D
20 = -10.7 (c 1, CHCl3) 55:45 er. HPLC (Chiralpak AD-H, 
2-propanol 10% in  hexane, flow 1.0 mL min, 9.3 min (minor), 
15.6 min (major). Exo-4j(Chiralpak AD-H, 2-propanol 10% in  
hexane, flow 1.0 mL min, 9.1 min (minor), 17.4 min (major). 
IR (neat): 1257, 1549, 1731 cm-1. 1H-NMR (300 MHz, CDCl3) 
δ: 1.19 (s, 3H, CCH3), 3.25 (br, 1H, NH), 3.86 (s, 3H, 
CO2CH3), 4.52 (d, J = 6.1 Hz, 1H, CHC), 5.08 (d, J = 7.4 Hz, 
1H, CHN), 5.65 (dd, J = 7.4, 6.1 Hz, 1H, CHNO2), 7.23-7.49 
(m, 10H, ArH). 13C-NMR (75 MHz, CDCl3) δ: 22.0 (CCH3), 
52.9 (CHC), 56.9 (OCH3), 64.9 (CHN), 68.8 (CCH3), 95.6 
(CHNO2), 126.8 (ArC), 128.0 (ArC), 128.5 (ArC), 128.6 
(ArC), 128.7 (ArC), 128.8(ArC), 135.3(ArC), 135.5(ArC), 
174.7(CO). MS m/z (M+ - NO2) 281(45), 234(100), 219(17), 
193(37), 115(21). HRMS required for (C19H20N2O4): 
340.1422, found: 281.1428. 
 
(2S, 3R, 4R, 5S)-Methyl 2-isobutyl-4-nitro-3,5-
diphenylpyrrolidine-2-carboxylate (4k). 
According to P1, colorless prisms, n-hexane/Et2O 4:1. 
mp 105-107 ºC.  
[α]D
20 = 59.0 (c 1, CHCl3), 99:1 er; HPLC (Daicel Chiralpak 
AD-H), 2-propanol/n-hexane 10:90, flow rate 1.0 mL/min, tR 
9.9 min (major), 14.5 min (minor). IR (solid) νmax: 1230, 1545, 
1730 cm-1. 
1H NMR δ: 0.81 (d, J = 6.7 Hz, 3H, CH3), 1.04 (d, J = 6.7 Hz, 
3H, CH3), 1.57 (br. s, 1H, NH), 1.79 (td, J = 13.3, 6.7 Hz, 1H, 
CH), 1.96 (dd, J = 13.9, 5.7, Hz, 1H, CH2), 2.15 (dd, J = 13.9, 
6.9 Hz, 1H, CH2), 3.19 (s, 3H, CH3), 4.00 (d, J = 9.9 Hz, 1H, 
CHC), 4.75 (d, J = 9.2 Hz, 1H, CHNH), 5.23 (dd, J = 9.2, 9.2 
Hz, 1H, CHNO2), 7.14-7.22 (m, 2H, ArH), 7.25-7.47 (m, 6H, 
ArH), 7.54-7.61 (m, 2H, ArH). 
13C NMR δ: 22.8, 24.3 (2xMe), 25.6 (CH2), 46.2 (CHCH2), 
51.8, 62.7 (2xCHPh), 66.1 (CCO2), 73.2, 94.9 (CHNO2), 
126.9, 127.7, 128.2, 128.6, 128.9, 129.1, 135.6, 137.2 (ArC), 
174.5 (CO).  
MS m/z: 337 (M+-NO2, 25%), 193(100), 115(20). 
HRMS required for (C22H26N2O4-NO2): 321.1729; found: 
321.1750. EA required for C22H26N2O4: C 69.1, H 6.9, N 7.3; 
found: C 69.5, H 6.8, N 7.4%. 
 
(2S,3R,4R,5S)-Methyl 2-benzyl-4-nitro-3,5-
diphenylpyrrolidine-2-carboxylate (4l). 
According to P1, colorless oil.  
[α]D
20 = 25.2 (c 1,0 CHCl3), >99:1 er. HPLC (Daicel Chiralpak 
AD-H), 2-propanol/n-hexane 10:90, flow rate 1.0 mL/min, tR 
20.8 min (minor), 30.1 min (major).  
IR (neat) νmax: 1208, 1547, 1723, 2946 cm-1. 
1H NMR δ: 2.49 (br. s, 1H, NH), 3.22 (s, 3H, OCH3), 3.32 (d, J 
= 13.6 Hz, 1H, CH2), 3.42 (d, J = 13.5 Hz, 1H, CH2), 4.15 (d,  
J = 9.7 Hz, 1H, CHCCC), 4.67 (d, J = 9.0 Hz, 1H, CHPh), 5.23 
(dd, J = 9.4, 9.4 Hz, 1H, CHNO2), 7.15-7.56 (m, 15 H, ArH).  
13C NMR δ: 42.8 (CH2), 51.9 (CHPh), 60.3 (CH3), 65.8 
(NCHPh), 73.6 (qC), 95.1 (CHNO2), 127.0, 127.1, 127.9, 
128.3, 128.3, 128.4, 129.0, 129.1, 130.5, 135.8, 136.0, 137.5 
(ArC), 173.42 (CO). 
MS m/z: 326 (M+-Bn, 19%), 325 (97), 279 (20), 278 (100), 246 
(76), 219 (41), 193 (20), 115(29). 
HRMS required for (C25H24N2O4-CO2Me): 357.1608; found 
357.1604. 
 
(2S,3S,4R,5S)-Methyl 4-nitro-3-phenyl-5-(2-
tolyl)pyrrolidine-2-carboxylate (4m). 
According to P2-AgOBz, pale yellow needles, n-hexane/Et2O 
5:1. 
mp 71-72 ºC.  
[α]D20 = 108.2 (c 0.3, CHCl3) 95:5 er.HPLC (Daicel Chiralpak 
AD-H), 2-propanol/n-hexane 10:90, flow rate 1.0 mL/min, tR 
20.4 min (minor), 25.3 min (major). 
IR (solid) νmax: 1213, 1548, 1736 cm-1.  
1H NMR δ: 2.38 (s, 3H, CCH3), 2.55 (br. s, 1H, NH), 3.28 (s, 
3H, OCH3), 4.43 (dd, J = 10.1, 7.1 Hz, 1H, CHPh), 4.50 (d, J = 
9.4 Hz, 1H, CHCO), 5.10 (d, J = 8.8 Hz, 1H, CHTol), 5.34 (dd, 
J = 8.7, 8.7 Hz, 1H, CHNO2), 7.20-7.37 (m, 9H, ArH).  
13C NMR δ: 19.2 (CCH3), 51.8 (CHPh), 54.0 (OCH3), 63.3 
(CHCO), 64.0 (CHTol), 93.8 (CHNO2), 125.6, 126.8, 127.7, 
128.2, 128.6, 128.7, 130.9, 135.9, 135.6, 137.1 (ArC), 172.1 
(CO). 
MS m/z: 359 (M+-NO2, 21%), 340 (2), 293 (12), 234 (61), 207 
(100), 191 (12), 131 (20), 115 (25). 
EA required for C19H20N2O4: C 67.0, H 5.9, N 8.2%; found C 
66.9, H 5.5, N 8.4%. 
 
(2S,3S,4R,5S)-Methyl 4-nitro-3-phenyl-5-(3-
tolyl)pyrrolidine-2-carboxylate (4n).  
According to P2-AgOBz, pale yellow prisms, n-hexane/Et2O 
5:1. 
mp 56-58 ºC. 
[α]D20 = 99.8 (c 0.74, CHCl3) 95:5 er(after recrystallization). 
HPLC (Daicel Chiralpak AD-H), 2-propanol/n-hexane 10:90, 
flow rate 1.0 mL/min, tR 15.1 min (minor), 19.9 min (major).  
IR (solid) νmax: 1213, 1265, 1549, 1737 cm-1. 
1H NMR δ: 2.22 (br. s, 1H, NH),  2.39 (s, 3H, CH3C), 3.30 (s, 
3H, OCH3), 4.40 (dd, J = 8.7, 8.7 Hz, 1H, CHPh), 4.53 (d, J = 
9.2 Hz, 1H, CHCO), 4.77 (d, J = 8.5 Hz, 1H, CHTol), 5.26 (dd, 
J = 8.4, 8.4 Hz, 1H, CHNO2), 7.19-7.38 (m, 9H, ArH). 
13C NMR δ: 21.5 (CCH3), 52.0 (CHPh), 53.7 (OCH3), 64.0 
(CHCO), 67.4 (CHTol), 94.5 (CHNO2), 123.9, 127.6, 127.8, 
128.2, 128.4, 128.8, 129.0, 129.4, 129.9, 138.9 (ArC), 171.6 
(CO). 
MS m/z: 294 (M+-NO2, 21%), 234 (75), 207 (100), 131 (20), 
115 (29). 
HRMS required for (C19H20N2O4-NO2): 294.1572, found: 
294.1565. 
EA required for C19H20N2O4: C 67.0, H 5.9, N 8.2%; found: C 
67.2, H 6.0, N 8.2%. 
 
(2S,3S,4R,5S)-Methyl 4-nitro-3-phenyl-5-(4-
tolyl)pyrrolidine-2-carboxylate (4o). 
According to P2-AgOTf, pale yellow prisms, n-hexane/Et2O 
8:1. 
mp 90-92 ºC. 
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[α]D20 = 81.9 (c 0.72, CHCl3) 97:3 er.HPLC (Daicel Chiralpak 
AD-H), 2-propanol/n-hexane 10:90, flow rate 1.0 mL/min, tR 
22.3 min (minor), 28.0 min (major). 
IR (solid) νmax: 1220, 1545, 1725 cm-1. 
1H NMR δ: 2.30 (s, 3H, CH3C), 2.65 (br. s, 1H, NH), 3.21 (s, 
3H, OCH3), 4.29 (dd, J = 9.0, 9.0 Hz, 1H, CHPh), 4.41 (d, J = 
9.1 Hz, 1H, CHCO), 4.64 (d, J = 8.4 Hz, 1H, CHTol), 5.12 (dd, 
J = 8.1, 8.1 Hz, 1H, CHNO2), 7.14-7.38 (m, 9H, ArH). 
13C NMR δ: 21.2 (CCH3), 51.8 (CHPh), 53.8 (OCH3), 64.2 
(CHCO), 67.5 (CHTol), 95.1 (CHNO2), 126.9, 127.8, 128.1, 
128.8, 129.2, 129.7, 134.5, 135.9 (ArC), 171.9 (CO). MS m/z: 
294 (M+-NO2, 10%), 293 (25), 234 (85), 207 (100), 191 (16), 
131 (26), 115 (26). 
HRMS required for (C19H20N2O4-NO2): 294.1572; found: 
294.1562. 
EA required for C19H20N2O4: C 67.0, H 5.9, N 8.2%; found: C 
66.8, H 5.8, N 7.9%. 
 
(2S,3S,4R,5S)-Methyl 5-(4-methoxyphenyl)-4-nitro-3-
phenylpyrrolidine-2carboxylate (4p). 
According to P2-AgOTf, yellow oil. 
[α]D
20 = 95.2 (c 1.9, CHCl3) 98:2 er. HPLC (Chiralpak AD-H, 
2-propanol 30% in  hexane, flow 1.0 mL min, 19.9 min 
(minor), 25.2 min (major). 
IR(neat): 1177, 1213, 1248, 1513, 1547, 1735 cm-1.  
1H-NMR (300 MHz, CDCl3) δ: 3.29 (s, 3H, PhOCH3), 3.83 (s, 
3H, CO2CH3), 4.41 (dd, J = 8.4, 8.4 Hz, 1H, CHPh), 4.50 (d, J 
= 9.2 Hz, 1H, CHCO), 4.74 (d, J = 8.5 Hz, 1H, CHN), 5.22 
(dd, J = 8.4, 8.4 Hz, 1H, CHNO2), 6.95 (d, J = 8.7 Hz, 2H, 
ArH), 7.19-7.36 (m, 5H, ArH), 7.50 (d, J = 8.7 Hz, 2H). 
13C NMR (101 MHz, CDCl3) δ: 172.01, 160.07, 135.88, 
129.53, 128.77, 128.14, 127.82, 127.70, 114.46, 113.86, 95.07, 
77.34, 77.02, 76.70, 67.36, 64.18, 55.33, 53.67, 51.81. 
MS m/z (M+ - NO2) 309(35), 250(100), 223(88).207(39), 
147(47), 115(28). 
EA required for C19H20N2O5: C 64.0, H 5.7, N 7.9%; found: C 
63.8, H 5.8, N 7.9%. 
 
(2S,3S,4R,5S)-Methyl 5-(4-fluorophenyl)-4-nitro-3-
phenylpyrrolidine-2-carboxylate (4q). 
According to P2-AgOTf, pale yellow oil.  
[α]D
20 = 65.2 (c 1.2, CHCl3) 99:1er. HPLC (Daicel Chiralpak 
AD-H), 2-propanol/n-hexane 10:90, flow rate 1.0 mL/min, tR 
16.9 min (minor), 19.4 min (major). 
IR (neat) νmax: 1221, 1509, 1548, 1736 cm-1. 
1H NMR δ: 2.62 (br. s, 1H, NH), 3.30 (s, 3H, OCH3), 4.41 (dd, 
J = 8.2, 8.2 Hz, 1H CHPh), 4.50 (d, J = 9.1 Hz, 1H, CHCO), 
4.77 (d, J = 8.3 Hz, 1H, CHN), 5.21 (dd, J = 8.2, 8.2 Hz, 1H, 
CHNO2), 7.07-7.16 (m, 2H, ArH), 7.24-7.38 (m, 5H, ArH), 
7.56-7.62 (m, 2H, ArH). 
13C NMR δ: 51.8 (CHPh), 53.4 (OCH3), 64.0 (CHCO), 66.8 
(CHN), 94.9 (CHNO2), 115.9, 127.8, 128.2, 128.7, 128.8, 
133.7, 135.7, 161.7, 164.2 (ArC), 171.9 (CO). 
MS m/z: 297 (M+-NO2, 14), 238 (74), 211 (100), 135 (23), 133 
(20), 115 (21). 
HRMS required for (C18H17FN2O4-NO2) 297.1181; found: 
297.1175. 
 
(2S,3S,4R,5S)-Methyl 5-(4-bromophenyl)-4-nitro-3-
phenylpyrrolidine-2-carboxylate (4r). 
According to P2-AgOTf, colorless prisms, n-hexane/Et2O 3:1. 
mp 149-151 ºC. 
[α]D20 = 66.4 (c 1, CHCl3) 99:1 er. HPLC (Daicel Chiralpak 
AD-H), 2-propanol/n-hexane 10:90, flow rate 1.0 mL/min, tR 
23.6 min (minor), 25.5 min (major). 
IR (solid) νmax: 1213, 1547, 1738 cm-1. 
1H NMR δ 2.73 (br. s, 1H, NH), 3.31 (s, 3H, OCH3), 4.40 (dd, 
J = 8.7 Hz, 1H, CHPh), 4.53 (d, J = 9.1,  1Hz, CHCO), 4.80 (d, 
J = 8.4 Hz, 1H, CHN), 5.23 (dd, J = 8.4, 8.4 Hz, 1H, CHNO2), 
7.17-7.29 (m, 2H, ArH), 7.31-7.33 (m, 3H, ArH), 7.44-7.51 (m, 
2H, ArH), 7.55-7.61 (m, 2H, ArH). 
13C NMR δ: 52.0 (CHPh), 53.2 (OCH3), 63.8 (CHCO), 66.4 
(CHN), 94.1 (CHNO2), 123.3, 127.7, 127.8, 128.9, 129.4, 
132.3, 132.4, 134.9 (ArC), 171.4 (CO). 
MS m/z:359 (M+-NO2, 21%), 357 (22), 300 (65), 298 (68), 273 
(97), 271 (100), 219 (30), 218 (14), 197 (15), 195 (21), 192 
(96), 191 (35), 115 (17), 114 (32). 
HRMS required for (C18H17BrN2O4-NO2): 359.0343; found: 
359.0334. 
EA required for C18H17BrN2O4: C 53.3, H 4.2, N 6.9%; found: 
C 52.9, H 4.0, N 6.8%. 
 
(2S,3S,4R,5S)-Methyl 5-(naphth-2-yl)-4-nitro-3-
phenylpyrrolidine-2-carboxylate (4s). 
According to P2-AgOTf, colorless prisms, n-hexane/Et2O 5:1. 
mp 76-78 ºC. 
[α]D20 = 46.0 (c 0.6, CHCl3) 92:8er.HPLC (Daicel Chiralpak 
AD-H), 2-propanol/n-hexane 10:90, flow rate 1.0 mL/min, tR 
19.9 min (minor), 23.0 min (major). 
IR (solid) νmax: 1550, 1743 cm-1. 
1H NMR δ: 2.83 (br. s, 1H, NH), 3.33 (s, 3H, OCH3), 4.46 (dd, 
J = 8.7, 8.7 Hz, 1H CHPh), 4.60 (d, J = 9.1 Hz, 1H, CHCO), 
5.02 (d, J = 8.5 Hz, 1H, CHNaph), 5.41 (dd, J = 8.4, 8.4 Hz, 
1H, CHNO2),  7.26-7.36 (m, 5H, ArH), 7.51-7.53 (m, 2H, 
ArH), 7.73 (dd, J = 8.5, 1.8 Hz, 1H, ArH), 7.72-7.9 (m, 4H, 
ArH). 
13C NMR δ: 52.0 (CHPh), 53.5 (OCH3), 64.0 (CHCO), 
67.4(CHNf), 94.1 (CHNO2), 123.9, 126.7, 127.8, 128.2, 128.4, 
128.5, 128.6, 128.9, 129.3, 129.4, 133.2, 133.6, 134.9, 135.9 
(ArC), 171.8 (CO). 
MS m/z: 329 (M+-NO2, 38%), 271 (19), 270 (88), 244 (20), 
243 (100), 227 (14), 167 (34), 165 (27), 115(26). 
HRMS required for (C22H20N2O4) 376.1442, found: 376.1432. 
EA required for C22H20N2O4: C 70.2, H 5.4, N 7.4%; found C 
69.8, H 5.5, N 7.4%. 
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